https://www.pharmaceutical-technology.com/data-insights/diacc-3010-evexta-bio-lymphoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-349593&utm_campaign=recommended-articles-pi
DIACC-3010 is under clinical development by Evexta Bio and currently in Phase I for Lymphoma.
diaccbiolymphomalikelihoodapproval
https://www.biometricupdate.com/202110/diacc-partners-up-to-advance-canadian-digital-id
A pair of tech organizations in Canada have agreed to work together to advance innovation for digital identity management, security, and data privacy.
digital iddiaccpartnersadvancecanadian
https://www.biometricupdate.com/202204/majority-of-canadians-support-digital-ids-want-control-over-data-diacc-survey
78 percent believe it is important that federal and provincial governments move quickly to enable a safe and secure digital identity for all Canadians.
digital idsmajoritycanadianssupportwant